. Author manuscript; available in PMC: 2015 Sep 1.

Published in final edited form as: Eur Respir J. 2014 Apr 17;44(3):675–684. doi: 10.1183/09031936.00220513

TABLE 2.

Central lung zone and area above the curve analysis

	Controls	Paediatric CF	Adult CF
	Controls	Paediatric CF	IS	HS
Central MCC %	36.2 ± 18.0	35.2 ± 18.0	32.7 ± 13.5	45.7 ± 23.7
Central DTPA %	45.4 ± 16.6	57.1 ± 20.6	56.0 ± 19.0	62.8 ± 21.7
Central ABS %	9.2 ± 10.0	21.9 ± 5.0^**	23.3 ± 13.0^*	17.1 ± 12.2^#
AAC_Tc	18.6 ± 9.4	14.5 ± 8.8	14.3 ± 6.3	26.8 ± 10.8^##
AAC_In	25.9 ± 9.6	30.6 ± 11.4	30.5 ± 10.3	38.8 ± 7.7^#
AAC_ABS	7.3 ± 3.5	16.1 ± 7.7^**	16.2 ± 8.8^**	12.0 ± 6.8^##

Data are presented as mean ± SD. CF: cystic fibrosis; IS: isotonic saline; HS: hypertonic saline; MCC: mucociliary clearance; DTPA: diethylene triamine penta-acetic acid; ABS: DTPA absorption; AAC_Tc: area above the technetium-99m–sulfur colloid retention curve; AAC_In: area above the ¹¹¹In-DTPA retention curve; AAC_ABS: area above the ABS curve.

: p<0.05 versus controls;

^**

: p<0.01 versus controls;

: p<0.05 versus adult CF subjects with IS treatment;

^##

: p<0.01 versus adult CF subjects with IS treatment.